Keratinocyte differentiation and upregulation of ceramide synthesis induced by an oat lipid extract via the activation of PPAR pathways

Experimental Dermatology

Volumn 24, Issue 4, 2015, Pages 290-295

  Chon, Su Hyoun ^a   Tannahill, Ruth ^a   Yao, Xiang ^b   Southall, Michael D ^a   Pappas, Apostolos ^a  

^a JOHNSON AND JOHNSON   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Ceramide; Keratinocyte differentiation; Oat lipid; Peroxisome proliferator activated receptor; Skin barrier

Indexed keywords

CERAMIDE; LIPID; OAT LIPID EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SKIN LIPID; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; VEGETABLE OIL;

ABCA12 GENE; ARTICLE; BETA GLUCOCEREBROSIDASE GENE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE; GENE INDUCTION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INVOLUCRIN GENE; KERATINOCYTE; LIPOGENESIS; OAT; REAL TIME POLYMERASE CHAIN REACTION; SPHINGOMYELIN PHOSPHODIESTERASE 3 GENE; SPRR GENE; TRANSFORMED CELL LINE; TRANSGLUTAMINASE 1 GENE; UPREGULATION; AVENA; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; METABOLISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AVENA; CELL DIFFERENTIATION; CELLS, CULTURED; CERAMIDES; HEK293 CELLS; HUMANS; KERATINOCYTES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLANT EXTRACTS; PLANT OILS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84925943909     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12658     Document Type: Article

References (41)

1. Schmuth M, Jiang Y J, Feingold K R et al. J Lipid Res 2008: 49: 499-509.
2. Chong H C, Tan M J, Tan N S et al. J Cell Biol 2009: 184: 817-831.
3. Kippenberger S, Loitsch S M, Bernd A et al. J Invest Dermatol 2001: 117: 1430-1436.
4. Eberlein B, Eicke C, Ring J et al. J Eur Acad Dermatol Venereol 2008: 22: 73-82.
5. De B C, Roo-Rodriguez E, Msika P et al. J Dermatolog Treat 2011: 22: 359-365.
6. Grais M L. AMA Arch Derm Syphilol 1953: 68: 402-407.
7. Dull B J. Cosmet Toiletries 1997: 112: 77-81.
8. Dick L A. Arch Pediatr 1958: 75: 506-508.
9. Sompayrac L M, Ross C. J Fla Med Assoc 1959: 45: 1411-1412.
10. Department of Health and Human Services. Fed Regist 1989: 54: 40808.
11. Department of Health and Human Services. Fed Regist 2003: 68: 33362-33381.
12. Collins F. J Agric Food Chem 1989: 37: 60-66.
13. Bryngelsson S, Dimberg L H, Kamal-Eldin A. J Agric Food Chem 2002: 50: 1890-1896.
14. Dimberg L H, Theander O, Lingnert H. Cereal Chem 1993: 70: 637-641.
15. Peterson D M, Hahn M J, Emmons C L. Food Chem 2002: 79: 473-478.
16. Sur R, Nigam A, Southall M et al. Arch Dermatol Res 2008: 300: 569-574.
17. Wallo W, Nebus J, Southall M et al. 65th annual meeting of the American Academy of Dermatology Washington, DC 2007.
18. Schmaus G, Herrmann M, Joppe H. 23rd Congress of the International Federation of Societies of Cosmetic Chemists 2004.
19. Kurtz E S, Wallo W. J Drugs Dermatol 2007: 6: 167-170.
20. Banas A, Debski H, Stymne S et al. J Exp Bot 2007: 58: 2463-2470.
21. Weerheim A, Ponec M. Arch Dermatol Res 2001: 293: 191-199.
22. Komuves L G, Hanley K, Feingold K R et al. J Invest Dermatol 2000: 115: 353-360.
23. Schmuth M, Haqq C M, Feingold K R et al. J Invest Dermatol 2004: 122: 971-983.
24. Michalik L, Wahli W. Biochim Biophys Acta 2007: 1771: 991-998.
25. Akiyama M. Dermatoendocrinol 2011: 3: 107-112.
26. Rivier M, Castiel I, Michel S et al. J Invest Dermatol 2000: 114: 681-687.
27. Akiyama M, Sugiyama-Nakagiri Y, Shimizu H et al. J Clin Invest 2005: 115: 1777-1784.
28. Jiang Y J, Uchida Y, Feingold K R et al. J Biol Chem 2009: 284: 18942-18952.
29. Hanley K, Jiang Y, Feingold K R et al. J Invest Dermatol 1998: 110: 368-375.
30. Westergaard M, Henningsen J, Kristiansen K et al. J Invest Dermatol 2001: 116: 702-712.
31. Kim D J, Bility M T, Peters J M et al. Cell Death Differ 2006: 13: 53-60.
32. Romanowska M, Seidel H, Foerster J et al. J Invest Dermatol 2008: 128: 110-124.
33. Hack K, Reilly L, Foerster J et al. PLoS One 2012: 7: e37097.
34. Westergaard M, Henningsen J, Kristiansen K et al. J Invest Dermatol 2003: 121: 1104-1117.
35. Forman B M, Chen J, Evans R M. Proc Natl Acad Sci U S A 1997: 94: 4312-4317.
36. Wahli W, Michalik L. Trends Endocrinol Metab 2012: 23: 351-363.
37. Fu J, Gaetani S, Piomelli D et al. Nature 2003: 425: 90-93.
38. Lo V J, Fu J, Piomelli D et al. Mol Pharmacol 2005: 67: 15-19.
39. Madison K C. J Invest Dermatol 2003: 121: 231-241.
40. Sigruener A, Tarabin V, Schmitz G et al. Exp Dermatol 2013: 22: 677-679.
41. Man M Q, Choi E H, Feingold K R et al. J Invest Dermatol 2006: 126: 386-392.